程锦国基于“开导之后宜补论”治疗前部缺血性视神经病变的学术思想探析

doi:10.3760/cma.j.cn115909-20210625-00253

Abstract
Figure/Table
References (12)
Related Citation (1)

Download: PDF (3399 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Guide

Abstract “Surveying the Yao Letters: The Theory of Supplementation after Enlightenment”, proposes corresponding treatment theories for ophthalmological diseases. Director Cheng (Cheng Shi) applies his theories to the clinical treatment of anterior ischemic optic nerve diseases. He divides the treatment of diseases into early,middle and late stages according to the rise and fall of evils and positives. In the latter two phases, the key is to eliminate evils in the early stage, focusing on “opening and activating blood stasis”. In the middle and late stages, the focus is on protecting righteous qi, treating both symptoms and root causes, focusing on “replenishing qi and blood, and cultivating the liver and kidney”, and taking into account opening and activating stasis. “The Theory of Supplementation after Enlightenment” is mature, and Cheng Shi has had significant effects in clinical application. Now, combining medical records to analyze Cheng Shi’s academic thoughts, it provides ideas for improving the success rate of disease treatment.

Key words： theory of supplementation after enlightenment anterior ischemic optic nerve disease Cheng Jinguo famous doctor’s experience

Received: 25 June 2021

PACS:

Fund:Zhejiang Province Chinese Medicine Major Research Project (2018ZY011); Zhejiang Province Chinese Medicine Science and Technology Plan Project (ZY202003)

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Feng Wang
	Shengjin Xiang
	Jinguo Cheng

Cite this article:

Feng Wang,Shengjin Xiang,Jinguo Cheng. Cheng Jinguo’s Academic Thoughts on the Treatment of Anterior Ischemic Optic Neuropathy Based on “The Theory of Supplementation after Enlightenment”[J]. Chinese Journal of Optometry Ophthalmology and Visual science, 2022, 24(2): 81-85.

URL:

https://www.cjoovs.com/EN/10.3760/cma.j.cn115909-20210625-00253 OR https://www.cjoovs.com/EN/Y2022/V24/I2/81

[1]	Morrow MJ. Ischemic Optic Neuropathy. Continuum(Minneap Minn), 2019, 25(5): 1215-1235. DOI: 10.1212/CON.0000000000000767.
[2]	Hattenhauer MG, Leavitt JA, Hodge DO, et al. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol, 1997, 123(1): 103-107. DOI: 10.1016/s0002-9394(14)70999-7.
[3]	康莉, 罗向霞, 杨敏, 等. 前部缺血性视神经病变的治疗进展.国际眼科杂志, 2018, 18(10): 1815-1818. DOI: 10.3980/j.issn.1672-5123.2018.10.13.
[4]	Parsa CF. The 14th hoyt lecture ischemic optic neuropathy: the evolving profile, 1966-2015: comment. J Neuroophthalmol,2017, 37(2): 218-219. DOI: 10.1097/WNO. 0000000000000525.
[5]	傅仁宇. 审视瑶函. 北京: 人民卫生出版社, 2006: 27-28.
[6]	林志辉, 魏丽娟, 周丹, 等. 基于“开导之后宜补论”针刺治疗弱视. 长春中医药大学学报, 2014, 30(2): 331-333. DOI: 10.13463/j.cnki.cczyy.2014.02.055.
[7]	周丹, 刘利哲, 张桐楠, 等. 基于“开导之后宜补论”治疗消渴内障的经验探析. 中国中医眼科杂志, 2016, 26(1): 61-63.DOI: 10.13444/j.cnki.zgzyykzz.2016.01.017.
[8]	张邓民. 张望之治疗内障眼病经验. 光明中医, 1997(2): 36-38. DOI: CNKI: SUN: GMZY.0.1997-02-016.
[9]	杜红彦, 李志英. 中医、中西医结合诊治视神经疾病学术经验总结. 广州: 广州中医药大学, 2014.
[10]	曹玲英, 游志鹏, 范慧敏. 中药防治视网膜缺血再灌注损伤的研究进展. 实用临床医学, 2019, 20(8): 101-104. DOI: 10.13764/j.cnki.lcsy.2019.08.036.
[11]	Hayreh SS. Risk factors in AION. Ophthalmology, 2001,108(10): 1717-1718. DOI: 10.1016/s0161-6420(01)00738-2.
[12]	唐娜, 姜小涵, 唐乐微, 等. 胡臻主任应用升阳疗法治疗眼科疾病举隅. 中华眼视光学与视觉科学杂志, 2020, 22(5): 326-332. DOI: 10.3760/cma.j.cn115909-20200205-00027.